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In response to Bootoulas and Leier, our findings with zatebndine do 
not just relate to a Jack of an additive e&t on exercise toterance when 
the drug is adminded to patients with angina ~wtoris already 
receiving nifediie (1). There are reports showing that zatebradine is 
Iem elk&e than long-acting dikiazem on exerck tolerana when 
uaedasmonotherapy(2)inp&entswithanginapectorisamJno 
d&rent tknn placebo in doub!e-blii randomii trials (3). There are 
alsodatasugedngthatzatebradineisle9seffectivethanpropraor!d 
inpatients~~anginapeaorisdeqpileshnilarredudiominhaartr3te. 
ItistheCombiMtiottoftbesedhliCalerrperieafesthatmadela 
ptoposethatnegativeinotropyorsomemetabohiprotectiveact~or 
both, may be more important than heart rate reduction in the 
an- effects of rate-lowering cabzium-entry and beta-adrenergic 
bhxking agents (4). Thii is also wggesmd by the wccemfnl experience 
ofMos3etal.(5)inusingintematpacingto bmease hearr rate when 
usinghigkdosebeta-blockadetonlievesymptornsinpatientswith 
refractory angina pectoris and bradyxrdia. 
We did not evaluate diasrolii time, systolic ejection tkx. col!ateraJ 
tin&m or indexes of ieti ventricular functmn in our study and m 
respondtosomeofthespeciticrematirsraisedbyBondoutasand 
bier. 
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Dobutamine Stress Echocardiography in 
Orthotopic Heart Transplant Recipients 
We read aith great interest the report by Derumeaua et al. (1) on the 
tyahmtion of transptdm coronary ark0 disease by dobutamine strew 
echocardiography. The authors deserve to be commended for using 
quantitative coronary angiograplry as the reference standard to com- 
pare the dobutamine stress echoc;lrd~phic lindii. However, we 
would like to comment on the methods utilized to cakulate sensitiuity. 
speciticity and positive sod negative predictive vahte~ which may have 
impurtant imphitions on their find&s. la their study (1). the authors 
wed quantitative coronary angkgmphy as the reference Standard to 
evaluate the d&o& accuracy of dobutamine stress echrxardiogra- 
pby in 37 patients They report a sensitivity and speciticity of 86% and 
91%. respectively. The prcbkm is that these values (sensiti.%y, 
spxikity, positive and negative predictive vahxs) are not bawd on 
the comparative anatjsis of the rerult.5 ef dobutamine stress ecbwar- 
diaphy versus those of quantitathe arronaty angiography. To 
derive the vahes the authors made two major assumptionz 1) Any 
indusibie wall motion abnormality observed was atMutable to the 
merepresenceoffocalepicor~an~lesiomrather 
than sigoifkant (>50%) tesiom. 2) Aft focal efkardial coronary 
ksions~makderedplqdbgMlysignificantregardlessddegree 
of stem For example, in theu study, seven patients with mihl 
arq&pphii kens (<40’S) were cons&d to have true positive 
results sddy on the basis of the positive results by M&amine stress 
edlocardicgraphy. clbvkdy, this creates major problems in the 
amdysis d send&y, spedicily and pxitive and negative predii 
acunacy. it is immktent 1~ fbst i..s a test (quantitative coromy 
angiographyinthircase)asi;refereoceaaodardto~~therxy~ 
d dobbtarnine stress test results and then later to inwpomte insig 
r&cantcoronary&sionsiiSanglDgraphiEaUyabaonnal.Forhntance. 
whenstres~diogrdphyresultswerepoaitiveinthepreseooed 
ang&r@cfesiomasminimalas15%~t.hayaren:caaidend 
“true positi” in the caknlation d sensirivitv, sqkxs&y and positive 
and negative prtdc& *abJes. 
Without adher&& to strict criteria bawd on quantitative at@gm- 
phy(refereoQdar,~),it~bedidiruhtolmosrthefabepaitiw 
rateof~stressectumrdiogqrhymheut~trecip 
ients Most illvc*m colT3ider ai% steno5is G3Q@+hk 
signifium stenosis (2-5). The authors cl?rrectly point m tk limit-a-- 
tionsdcoror~atya@ogra&in .assesngleriunseverit)iiahearl 
transplant re;ipienIs. cormury cza&p+y is Lunm 10 un&resti- 
matethesweri~oftnnk@ngcoronaryute~diiinbeart 
tramplam recipds (6). However. at present, it is prematore to 
ozinderlbbataminesnescdwmrdiopraphythedLgooslrtestd 
choicefc..nmnpbmtoaonvyvlerydiseaseandasasubstjnuefor 
cnronzq at+gn& as tk reference standard. 
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study by Deameaux et al. (I) it is not possible to calcuiate specificity 
beeause we do not know the actual false positive rate. For instance, 
does an akrmal msponse on the dobutamine stress test in a patient 
with 15% coronary stenosis represent a fake positive result on the 
dobutamine stress echncardiogram or a false negativr lesuh on the 
awonary angiogram? CC one recalculates their data taking into account 
au&mphii steoosis ZW% as the reference for significant disease. 
different values for sensitivity, specScity and positive and negative 
pm&be values emerge. The sensitivity, specificity and positive and 
negative predictive values are KW%. 77%. 50% and RKW, respec- 
tive@ Thus, the recalculated estimate of high sensitivity and negative 
predictiie value can be interpreted to suggest that dobutamine stress 
e&xard@aphy is an excellent screening test for transplant coronary 
artery disease and is consistent with our previous report (2). Finally. it 
can be hypothesiaed that compared with angiography, dobutamine 
dii frequent~o&ved in heart transplant recipients but severely 
underestimated by coronary angCography. However, the extent to 
which this hypoksii is true can only be determined by large muiti- 
center ciinical studies. Evaluation in experimental models of transplant 
atherosclerosis may also be necessary to allow direct morphologic and 
hhtopattmlogic correlation of observed underestimation of angio- 
graphic findings in transplant coronary artery disease in humans. 
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Altosah and Mohanty express their concern about the method we used 
to estabbh the sensitivity and spcilicity of dobutamine stress echo- 
cardii in 37 heal transplant recipients (1). They thought it . . 
uwcwslstent that we incorporated insi@cant coronary lesions as 
+ngiographicaliy abnomxd. We remiad them that we &arty defmed 
three groups of patients according to the= msuhs oC quantitative 
mmaary~,asfouowsgvoupI=normalresuhsonco~ 
uary~glwp2=ttom@kmtanouarylesions(<50% 
stetks~grarp3=~corollillyleaious(>~stenosis).We 
elearly~thereauhsofdobutamiuestressexhoeardiographyineach 
pn#lpofpatients~I=2of23positivetestresults;~2=5 
ob7~itivetestresults(ia.,~~~71%):~3=7of7positiw 
tat results (ie, sedivhy lb@%). Therefore, the metall sensitivity oC 
JACC Vol. 27, No. 4 
htarch 15. 1’)%:951-6 
Dobutamine stress echocardiography is designed to detect irh- 
emia, whereas coronaty angiography detects stenosis. In a recent study, 
Raptista et al. (2) established from receiver-operating curves the 
at&graphic cutoff values with the best predictive value for the 
development of ventricular wall motion abnormalities during dobut- 
amine stress echocardiography in 34 patients with conventional ath- 
erosclerotic coronary lesions. They found a 52% diameter stenosis to 
have functionai significance, with occurrence of wall motion abnormal- 
ities during dobutamine stress echocardiigraphy. However, it is now 
well established that graft atherosclerosis dir?ers from conventional 
atherosclerosis because of estensive, diise, concentric lesions related 
to a fibrous intimal hyperplasia that may be associated with focal 
stenosis (3). Therefore, coronary angiography may consistently under- 
estimate epicardial coronary stenosis, as recently assessed by intra- 
coronary ultrasound (4) and percent stenosis is a poor predictor of the 
functional significance of these ditbtse coronary lesions. That is the 
reason why we evaluated the sensitivity of dobutamine stress echocar- 
diigraphy to detect &hernia in heart transplant recipients with m Id 
lesions. usually considered nonsignhicant by quantitative coronary 
angiography. Moreover, we recendy demonstrated (5) that the posi- 
tivity of dobutamine stress echocardiography in patients with mild 
lesions may be related to smaller diameters of apparently healthy 
coronaty segments. 
Therefore, we conclude that dobutamine stress ecnocardiography 
is the noninvasive test of choice to detect ischemia related to graft 
atherosclerosis, even when coronary artery lesions appear to be 
nonsignificant on coronary angiography. 
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Preinparctian Angina as a Major Predictor of 
Left Ventricular Function and Long-Tern 
Prognosis After a I%st Q Wave 
Myocnudiai Intiion 
ARtaietal.(l)ceportthatpreiofaraionanginais~aritha 
favombkfa-hm+lcoumeaudhnpmvedsmvivalinpmienbwCtha 
bt Q wave myocardial intin. The preset of preinfarekm 
